Shifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacement
In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga.
To learn more about the FTC’s review of non-competes go here.